Painreform Stock Analysis

Painreform Stock Analysis Notes

The company has price-to-book ratio of 0.63. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Painreform recorded a loss per share of 136.93. The entity had not issued any dividends in recent years. The firm had 1:6 split on the 9th of September 2024. PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel. Painreform is traded on NASDAQ Exchange in the United States. To find out more about Painreform contact Ilan MBA at 972 3 7177050 or learn more at https://www.painreform.com.

Painreform Investment Alerts

Painreform Upcoming and Recent Events

Painreform Largest EPS Surprises

View All Earnings Estimates

Painreform Environmental, Social, and Governance (ESG) Scores

Painreform Stock Institutional Investors

Note, although Painreform's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Painreform Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.84 M.

Painreform Profitablity

Management Efficiency

Painreform has return on total asset (ROA) of (1.9507) % which means that it has lost $1.9507 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.1667) %, meaning that it created substantial loss on money invested by shareholders. Painreform's management efficiency ratios could be used to measure how well Painreform manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.89 in 2025. Return On Capital Employed is likely to drop to -1.2 in 2025. At this time, Painreform's Net Tangible Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 231.8 K in 2025, whereas Other Current Assets are likely to drop slightly above 1.3 M in 2025.

Technical Drivers

As of the 18th of January 2025, Painreform holds the Semi Deviation of 11.92, coefficient of variation of 907.74, and Risk Adjusted Performance of 0.1019. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Painreform, as well as the relationship between them.

Painreform Price Movement Analysis

Painreform Outstanding Bonds

Painreform Predictive Daily Indicators

Painreform Corporate Filings

Painreform Forecast Models

Painreform's time-series forecasting models are one of many Painreform's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Painreform's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Painreform prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Painreform shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Painreform. By using and applying Painreform Stock analysis, traders can create a robust methodology for identifying Painreform entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Painreform analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Painreform analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Painreform stock analysis indicators help investors evaluate how Painreform stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Painreform shares will generate the highest return on investment. By understating and applying Painreform stock analysis, traders can identify Painreform position entry and exit signals to maximize returns.

When running Painreform's price analysis, check to measure Painreform's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Painreform is operating at the current time. Most of Painreform's value examination focuses on studying past and present price action to predict the probability of Painreform's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Painreform's price. Additionally, you may evaluate how the addition of Painreform to your portfolios can decrease your overall portfolio volatility.